Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-018119
Filing Date
2024-01-29
Accepted
2024-01-29 16:15:07
Documents
8
Effectiveness Date
2024-01-29

Document Format Files

Seq Description Document Type Size
1 S-8 d703524ds8.htm S-8 49325
2 EX-5.1 d703524dex51.htm EX-5.1 8271
3 EX-23.2 d703524dex232.htm EX-23.2 1387
4 EX-23.3 d703524dex233.htm EX-23.3 1448
5 EX-99.1 d703524dex991.htm EX-99.1 99022
6 EX-FILING FEES d703524dexfilingfees.htm EX-FILING FEES 14084
7 GRAPHIC g703524g0123031211924.jpg GRAPHIC 1649
8 GRAPHIC g703524g0123031212594.jpg GRAPHIC 6662
  Complete submission text file 0001193125-24-018119.txt   186364
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276748 | Film No.: 24573826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)